Refractory tinea caused by Aspergillus niger

BMJ Case Rep. 2020 Jun 29;13(6):e235269. doi: 10.1136/bcr-2020-235269.

Authors

Mary Kathryn Mannix¹, Lisa Marlin², Ilene Rothman², Shamim Islam³

Affiliations

¹ Department of Pediatrics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA mmannix@buffalo.edu.
² Department of Pediatric Dermatology, John R Oishei Children's Hospital, Buffalo, New York, USA.
³ Department of Pediatrics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.

No abstract available

Keywords: dermatology; infectious diseases; paediatrics.

Publication types

Case Reports

MeSH terms

Antifungal Agents / therapeutic use
Aspergillus niger / isolation & purification
Child, Preschool
Humans
Male
Tinea Capitis / drug therapy
Tinea Capitis / microbiology*

Substances

Antifungal Agents